Cellectis (CLLS) Shares Outstanding (Diluted Average) (2015 - 2025)

Cellectis' Shares Outstanding (Diluted Average) history runs 8 years deep, the most recent figure standing at $60.0 for Q4 2025.

• In Q4 2025, Shares Outstanding (Diluted Average) fell 100.0% year-over-year to $60.0; the TTM figure through Dec 2025 stood at $60.0 (down 100.0% YoY), while the FY2025 annual figure was $60.0, down 100.0% from the prior year.
• Shares Outstanding (Diluted Average) was $60.0 for Q4 2025 at Cellectis, up from $10.0 in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $90.6 million in Q4 2024 to a low of $10.0 in Q3 2025.
• Historically, Shares Outstanding (Diluted Average) has averaged $26.4 million across 5 years, with a median of $1170.0 in 2021.
• The sharpest annual moves came in 2024 and 2025: Shares Outstanding (Diluted Average) jumped 58.85% in 2024, then tumbled 100.0% in 2025.
• A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $44.8 million in 2021, then increased by 1.62% to $45.5 million in 2022, then advanced by 25.17% to $57.0 million in 2023, then surged by 58.85% to $90.6 million in 2024, then sank by 100.0% to $60.0 in 2025.
• The last three Shares Outstanding (Diluted Average) figures came in at $60.0 (Q4 2025), $10.0 (Q3 2025), and $420.0 (Q2 2025), per Business Quant data.